L-056-2024

Agreement ID
L-056-2024
Lead IC
NCATS
Exclusivity
Exclusive
External Party
Oncala Bio, Inc. (A Civala Company)
Fiscal Year
2024
Territory
Worldwide
Execution Date
Effective Date
Export Date
Technologies
TAB-2373     Non-toxic Compounds that Inhibit the Formation and Spreading of Tumors
TAB-3470     The Use of Metarrestin for the Treatment of Pancreatic Cancer